Nanonisation can ‘bring back to life’ troublesome assets, says Nanoform CEO 09-Oct-2018 By Ben Hargreaves Nanoform specialises in producing APIs in a nanoparticle size range, which the company claims can significantly improve bioavailability and potentially change the fate of an asset in the clinic.